NCT03747302

Brief Summary

This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,043

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 20, 2018

Completed
22 days until next milestone

Study Start

First participant enrolled

December 12, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2019

Completed
3 years until next milestone

Results Posted

Study results publicly available

September 14, 2022

Completed
Last Updated

September 14, 2022

Status Verified

August 1, 2022

Enrollment Period

9 months

First QC Date

November 16, 2018

Results QC Date

June 7, 2022

Last Update Submit

August 19, 2022

Conditions

Keywords

AdolescenceAttitudesParentsVaccination

Outcome Measures

Primary Outcomes (1)

  • Change in Attitudes About HPV Vaccine

    Change in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(\<1 hour post messaging intervention) minus value at baseline.

    Post test completed < 1 hour post messaging intervention

Secondary Outcomes (1)

  • Behavioral Intention to Vaccinate Their Child With HPV Vaccine

    Ore test immediately before viewing message and post- test immediately after viewing message. Approximately one hour.

Study Arms (2)

HPV Messaging

EXPERIMENTAL

Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.

Other: Social Media Message about HPV and HPV vaccine

Control Message

OTHER

Subjects are randomized to receive one of five messages about electronic cigarettes.

Other: Social media message about risk of electronic cigarettes.

Interventions

Messages educate parents with facts about HPV vaccination.

HPV Messaging

Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.

Control Message

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • parents of children 9-14 years old

You may not qualify if:

  • non-parents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

Related Links

MeSH Terms

Conditions

Behavior

Interventions

Papillomavirus Vaccines

Intervention Hierarchy (Ancestors)

Viral VaccinesVaccinesBiological ProductsComplex Mixtures

Results Point of Contact

Title
Dr. Ardis Olson
Organization
Norris Cotton Cancer Center

Study Officials

  • Ardis L Olson, MD

    Trustees of Dartmouth College

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician, Professor of Pediatrics

Study Record Dates

First Submitted

November 16, 2018

First Posted

November 20, 2018

Study Start

December 12, 2018

Primary Completion

September 9, 2019

Study Completion

September 9, 2019

Last Updated

September 14, 2022

Results First Posted

September 14, 2022

Record last verified: 2022-08

Locations